ENTEROConsumer Services

Entero Healthcare Solutions Limited

Pharmacy Retail · ISIN INE010601016 · BSE 544122 · NSE EQ · FV ₹10
Last price
₹1,667
-3.76%today
What this company does

Entero Healthcare Solutions Limited operates in Pharmacy Retail, part of the Consumer Services sector. It booked ₹1,940 cr of revenue in its latest quarter (Q1 FY27) and kept 2.0% of sales as profit.

In the report:
51out of 100
Equitytale Health Score
Mixed

Healthier than 51% of companies in Consumer Services, on the 5 of 6 measures we could read for it. Each measure is ranked against the 34–46 companies that reported it.

Measures financial condition, not whether to buy. Learn what this score means · How this is calculated

Price momentum
neutral
RSI (14)
51

At close. Not part of the score.

Profitability & returns50

How much profit it earns on the money it employs

Balance sheet43

How much it owes, and whether earnings cover the interest

Cash quality25

Whether reported profit actually arrives as cash

Valuation59

What today's price implies, against our models or its peers

Governance & risk100

How much of the promoters' stake is pledged, and how much they hold · highest in its sector on what we could measure

Not measurable for this company: growth & consistency. Those pillars are left out of the score rather than counted as zero.

Is this company doing well?
not investment advice
Strengths
Makes a profit
Sales up 38% vs last year
Profit up 37% vs last year
Promoters hold 52%
No promoter shares pledged
Watch-outs
! Thin 2.0% net margin
! Operating cash flow is negative

What if I invest in ENTERO?

Set a growth rate and see what a monthly SIP would add up to. Your assumption, our arithmetic.

You would put in
₹12.00 lakh
120 instalments
At 10% a year, it would become
₹20.15 lakh

The starting rate is a round number, not a view on this company — this is your assumption, and the figure above is arithmetic on it. Returns are not steady year to year, and a real holding would not grow in a straight line. We do not publish price targets or predict returns.

Key ratios · latest quarter + price
₹1,667 -3.76%
latest close · 2026-09-17
52-wk low ₹1,18042 sessions so far52-wk high ₹1,920
Is it cheap or expensive?
What you pay for the profits, book value and cash flow. Higher isn't automatically worse — it can signal faster growth.
P/E ratio47.5High
LowAverageHigh
P/B ratio4.30High
Below bookModerateHigh
EV / EBITDA19.2High
LowAverageHigh
How good is the business?
How much profit it earns from its money and its sales.
Return on equity9.0%Fair
WeakFairStrong ▸15%
Return on capital17.4%Strong
WeakFairStrong
Net margin2.0%Thin
ThinDecentStrong
EBITDA margin5.2%Thin
ThinDecentHealthy
Is it financially safe?
How much it owes, and whether it can comfortably cover it.
Debt to equity0.32Comfortable
LowModerateHigh ▸1
Interest cover4.3×Okay
RiskyOkayStrong ▸5×
Current ratio1.58Healthy
Tight ◂1HealthyAmple
More figures
Market cap
₹7,254 cr
Book value
₹388
EPS
₹8.77
latest quarter
Net debt
₹420 cr
owes more than its cash
Enterprise value
₹7,673 cr
EBITDA
₹400 cr
annualised
EBIT
₹351 cr
annualised
Operating margin
4.5%
Return on assets
4.2%
Earnings yield
2.10%
P/S
0.93
Sales / share
₹1,783.4
Tax rate
22.5%
Face value
₹10
Shares
4.4 cr
Working capital
₹916 cr
Current assets
₹2,503 cr
Current liabilities
₹1,588 cr
Delivery %
48.4%
Strong / safeFairWeak / riskyValuation — a level, not good/badBands are general rules of thumb, not advice.

P/E, ROE, ROCE and margins are annualised from the latest quarter; per-share and balance-sheet ratios use the most recent balance sheet on file · prices as of 2026-09-17.

Worth vs price · from the FY 2026 report & filings
not investment advice
Hard to value confidentlyLow confidence
Too few reliable models — the filings don't support two independent estimates of value.
Models span ₹156₹156, midpoint ₹156

An educational model from the company's own filings, every assumption shown — not investment advice or a price target. Prices can stay above or below any model for years.

P&L · Q1 FY27 (consolidated)
Revenue from Operations₹1,940 cr
Other Income₹3 cr
Total Income₹1,944 cr
Cost of Materials₹0 cr
Purchases of Stock-in-Trade₹1,725 cr
Inventory Change (±)₹-6 cr
Employee Benefit Expense₹69 cr
Finance Costs₹21 cr
Depreciation & Amortisation₹12 cr
Other Expenses₹55 cr
Total Expenses₹1,876 cr
Profit before Tax₹67 cr
Tax Expense₹15 cr
Net Profit₹52 cr
Net margin on total income2.7%
Where the money goes · Q1 FY27
% of total income
Materials + stock-in-trade₹1,719 cr88.5%
Employee benefit expense₹69 cr3.6%
Finance costs₹21 cr1.1%
Depreciation & amortisation₹12 cr0.6%
Other expenses₹55 cr2.8%
Tax expense₹15 cr0.8%
Profit for the period₹52 cr2.7%
Total income ₹1,944 cradds up to ₹100 ✓
Quarterly results · consolidated (₹ cr)
MetricQ3 FY26Q4 FY26Q1 FY27
Revenue1,707 cr1,910 cr1,940 cr
Total income1,711 cr1,914 cr1,944 cr
Expenses1,663 cr1,856 cr1,876 cr
Profit before tax40 cr58 cr67 cr
Tax7 cr13 cr15 cr
Net profit (owners' share)28 cr28 cr38 cr
Net margin (owners' share, on revenue)1.6%1.5%2.0%
EPS (₹)6.356.448.77
YoY (latest quarter): total income +37.9% · net profit +37.3%
Balance sheet & cash flow · as of Mar 2026
Low debt
Total assets
₹3,600 cr
Shareholder equity
₹1,689 cr
parent shareholders
Total debt
₹567 cr
Cash
₹147 cr
Cash flow · H1 FY26
Operating
₹-57 cr
Investing
₹-55 cr
Financing
₹-39 cr
Peer comparison
Consumer Services · by market value (sector-level match)
CompanyPriceMarket capP/E
ETERNAL LIMITED₹322₹2.97 L cr805.9
Avenue Supermarts Limited₹3,711₹2.42 L cr70.3
Trent Limited₹2,789₹1.49 L cr71.7
Lenskart Solutions Limited₹680₹1.18 L cr132.8
The Indian Hotels Company Limited₹727₹1.03 L cr72.4
Meesho Limited₹207₹95,542 cr
FSN E-Commerce Ventures Limited₹324₹92,748 cr289.1
Info Edge (India) Limited₹1,265₹82,025 cr46.0
Swiggy Limited₹277₹72,443 cr
Same sector · latest reported numbers · not a recommendation.
Who owns it · 2026-06-30
No pledge
Promoter
52.4%
FII / Foreign
4.4%
DII / Domestic
15.5%
Retail / others
27.8%
Smart-money activity
Insider trades
SoldJayant Prakash · Key Managerial Personnel2,179 · ₹28.8 L29 Aug 24
SoldJayant Prakash · Key Managerial Personnel1,350 · ₹17.8 L21 Aug 24
Sold- · Employees/Designated Employees1,200 · ₹15.4 L19 Aug 24
Bulk / block deals
short · NSE11626 Aug 26
short · NSE1027 Mar 26
short · NSE52 Jun 25
Stake changes
SoldSurbhi Singh-Prasid Uno Family Trust→ 7.94% · 10.88 L24 Aug 26
SoldICICI Prudential Mutual Fund→ 2.15% · 12.42 L21 May 26
BoughtICICI Prudential Mutual Fund→ 5.02% · 21.82 L29 Dec 25
What shareholders were asked to approve

A company cannot decide everything on its own. Things like a top executive’s pay, issuing new shares, or re-appointing a director have to be put to the people who own the company, and they vote — one vote per share. So whoever owns the most shares has the most say.

Yearly shareholder meeting · 19 Aug 2026
See the official result
1
To receive, consider and adopt the Audited Standalone Financial Statements of the Company for the financial year ended March 31, 2026, together with the Reports of the Board of Directors and the Auditors thereon.
Backed by 100% of shareholders other than promotersneeded 50%
1.05 cr votes for, 127 against · 0% of mutual funds and other big investors said no
2
To receive, consider and adopt the Audited Consolidated Financial Statements of the Company for the financial year ended March 31, 2026, together with the Report of the Auditors thereon.
Backed by 100% of shareholders other than promotersneeded 50%
1.05 cr votes for, 127 against · 0% of mutual funds and other big investors said no
3
To appoint a director in place of Mr. Arun Sadhanandham (DIN: 08445197) Non-Executive Non Independent Director, who retires by rotation and being eligible, offers himself for re-appointment.
Promoters had a personal stake in this
Backed by 100% of shareholders other than promotersneeded 50%
1.04 cr votes for, 33,117 against · 1% of mutual funds and other big investors said no
4
Payment of Remuneration to Mr. Prabhat Agrawal (DIN: 07466382), Managing Director & CEO of the Company, for his remaining tenure
Promoters had a personal stake in this
Backed by 82% of shareholders other than promotersneeded 75%
86.00 L votes for, 18.79 L against · 35% of mutual funds and other big investors said no

Every vote count above is taken from the result the company filed with the stock exchange, certified by an independent counter. To work out what would have happened without the promoters, we simply remove their votes and re-apply the same legal bar the proposal had to clear. Nothing here is an estimate or an opinion.

Who controls this company, and what it pays them

Most Indian companies are controlled by a family or group — the promoters. The exchange requires them to be listed by name, including members who own no shares at all, and requires the company to disclose any business it does with them.

The promoter group — 31 named members
owning 52.4% between them · as of 2026-06-30
Orbimed Asia III Mauritius Limited38.00%
Prabhat Agrawal9.26%
Prem Sethi5.15%
Adya Agrawalno shares
Arti Mittalno shares
Asha Agrawalno shares
Holliday International Ltdno shares
Jaibhagwan Mittalno shares

Names and holdings from the company’s shareholding pattern filed with the exchange; transactions from the related-party note in its annual report. Every figure is as filed — these are legal, disclosed dealings, and what to make of them is your call.

Money it raised, and what it did with it

When a company raises money from investors, it has to say up front what the money is for. The rules then make it report, every three months until the money is gone, how much of each of those things it has actually paid for — so a promise made while asking for the money can be checked afterwards.

₹951 cr raised in Feb 2024 by selling shares to the public

As of Dec 2025, the company says it has spent 100% of what it set aside. ICRA Limited watches the spending on the exchange’s behalf.

Repayment/prepayment, in full or part, of certain borrowings availed of by our Company
100%
₹143 cr of ₹143 cr
Funding of long-term working capital requirements of the Company and its Subsidiaries during Fiscals 2025 and 2026
100%
₹480 cr of ₹480 cr
Pursuing inorganic growth initiatives through acquisitions
100%
₹237 cr of ₹237 cr
General corporate purposes
100%
₹95 cr of ₹95 cr

Every figure above is taken from the statement the company files with the stock exchange each quarter, for as long as money it has raised remains unspent. The only thing we work out is how much of each stated purpose has been paid for — one number divided by another from the same filing. Whether a plan that changed was a good change is not something a filing can tell you. See the filing

How the stock has moved · adjusted for splits & bonuses
Data from primary exchange filings · analysis tool, not investment advice.